Vimarsana
Biggest News Aggregation in the World

Jane Trust Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jane Trust Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jane Trust Foundation Today - Breaking & Trending Today

JAG Productions Will Close its Doors After Eight Years - Vimarsana News

JAG Productions Will Close its Doors After Eight Years

JAG Productions, the Vermont-based Black theater company, has announced it will close its doors after eight years of being open.

OUT Maine awarded $25,000 to support LGBTQ+ youth in Maine, improve mental health - Vimarsana News

OUT Maine awarded $25,000 to support LGBTQ+ youth in Maine, improve mental health

OUT Maine has received generous support from Jane’s Trust Foundation in the amount of $25,000 to continue its work with and for LGBTQ+ youth in Maine. OUT Maine was founded in 1996 as a volunteer-run organization that provided support for Midcoast...

OUT Maine awarded $25,000 to support LGBTQ+ youth in Maine - Vimarsana News

OUT Maine awarded $25,000 to support LGBTQ+ youth in Maine

ROCKLAND — OUT Maine has received generous support from Jane’s Trust Foundation in the amount of $25,000 to continue its work with and for LGBTQ+ youth in Maine.

Correcting abnormalities in solid tumor's blood vessels can improve efficacy of CAR-T cell therapy - Vimarsana News

Correcting abnormalities in solid tumor's blood vessels can improve efficacy of CAR-T cell therapy

A type of immune therapy called chimeric antigen receptor (CAR)-T cell therapy has revolutionized the treatment of multiple types of blood cancers but has shown limited efficacy against glioblastoma-;the deadliest type of primary brain cancer-;and other solid tumors.

Blood pressure drug losartan can prevent immunotherapy-induced edema in glioblastoma patients - Vimarsana News

Blood pressure drug losartan can prevent immunotherapy-induced edema in glioblastoma patients

Patients with glioblastoma-;the deadliest type of primary brain tumor-;may potentially benefit from immunotherapy medications called immune checkpoint inhibitors that stimulate an immune response against cancer cells.